Cas:1119450-11-1 2-(3,5,6-trifluoropyridin-2-yl)acetic acid manufacturer & supplier

We serve Chemical Name:2-(3,5,6-trifluoropyridin-2-yl)acetic acid CAS:1119450-11-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3,5,6-trifluoropyridin-2-yl)acetic acid

Chemical Name:2-(3,5,6-trifluoropyridin-2-yl)acetic acid
CAS.NO:1119450-11-1
Synonyms:(3,5,6-trifluoropyridin-2-yl)acetic acid
Molecular Formula:C7H4F3NO2
Molecular Weight:191.10700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.19000
Exact Mass:191.01900
LogP:1.12600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3,5,6-trifluoropyridin-2-yl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3,5,6-trifluoropyridin-2-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3,5,6-trifluoropyridin-2-yl)acetic acid Use and application,(3,5,6-trifluoropyridin-2-yl)acetic acid technical grade,usp/ep/jp grade.


Related News: That impacts airlines’ business, making it less financially attractive for them to fly those routes to China. 2-(3,5,6-trifluoropyridin-2-yl)acetic acid manufacturer Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. 2-(3,5,6-trifluoropyridin-2-yl)acetic acid supplier Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 2-(3,5,6-trifluoropyridin-2-yl)acetic acid vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 2-(3,5,6-trifluoropyridin-2-yl)acetic acid factory Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.